Skip to main content
Log in

Eruptive Xanthome bei Hypertriglyzeridämie

Eruptive xanthomas with hypertriglyceridemia

  • Kasuistiken
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Eruptive Xanthome sind häufig kutane Symptome einer erhöhten Plasmakonzentration triglyzeridreicher Lipoproteine und können Indikator einer unentdeckten Fettstoffwechselstörung, eines Diabetes mellitus oder einer Pankreatitis sein. Wir berichten über eine 42-jährige Patientin mit akut aufgetretenen disseminierten eruptiven Xanthomen aufgrund einer ausgeprägten Hyperlipidämie sowie dekompensiertem Diabetes mellitus bei akuter Pankreatitis. Nach optimierter Blutzucker- und Fettstoffwechseleinstellung bildeten sich die Hautläsionen wieder zurück. Eruptive Xanthome sollten frühzeitig diagnostiziert werden und zur weiterführenden Differenzialdiagnostik einschließlich der Stoffwechselparameter führen.

Abstract

Eruptive xanthomas are often associated with elevated plasma levels of triglyceride-rich lipoproteins and may be a marker for occult hyperlipidemia, diabetes mellitus or pancreatitis. A 42-year-old woman presented with the acute onset of disseminated eruptive xanthomas secondary to hyperlipidemia associated with diabetes and concomitant acute pancreatitis. She improved after optimized insulin therapy and intensified treatment of hyperlipidemia. Eruptive xanthomas should be diagnosed early and lead to further metabolic evaluations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Haves BB, Boyd AS (2005) Eruptive xanthomas. Papules may indicate unterlying lipid disorder. Postgrad Med 118: 11–12

    Google Scholar 

  2. Roller E, Schulte KW, Hengge U et al. (2004) Eruptive Xanthome. Hautarzt 55: 978–980

    PubMed  CAS  Google Scholar 

  3. Gajer GK, Krawczyk AK, Petrulewicz-Salamon IT (2006) Skin manifestation of mixed hyperlipidaemia in the course of decompensated diabetes (abstract). Wiad Lek 59: 265–268

    PubMed  Google Scholar 

  4. Dicken CH, Connolly SM (1980) Eruptive xanthomas associated with isotretinoin (13-cis-retinoid-acid). Arch Dermatol 116: 951–952

    Article  PubMed  CAS  Google Scholar 

  5. Haber C, Kwiterovich PO (1984) Dyslipoproteinemia and xanthomatosis. Pediatric Dermatology 1: 261–280

    Article  PubMed  CAS  Google Scholar 

  6. Calza L, Manfredi R, Chiodo F (2004) Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. J Antimicrob Chemother 53: 10–14

    Article  PubMed  CAS  Google Scholar 

  7. Zadák Z (2006) Internist’s view on skin manifestations of hyperlipidemia in diabetic patients (abstract). Vnitr Lek 52: 465–469

    PubMed  Google Scholar 

  8. Athyros VG, Giouleme OI, Nikolaidis NL et al. (2002) Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis. J Clin Gastroenterol 34: 472–475

    Article  PubMed  Google Scholar 

  9. Yadav D, Pitchumoni CS (2003) Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol 36: 54–62

    Article  PubMed  CAS  Google Scholar 

  10. Fleischmajer R, Schaefer EJ, Gal AE et al. (1983) Normolipemic subcutaneous xanthomatosis. Am J Med 75: 1065–1070

    Article  PubMed  CAS  Google Scholar 

  11. Mancuso G, La Regina G, Bagnoli M et al. (1996) Normolipidemic tendinous and tuberous xanthomatosis. Dermatology 193: 27–32

    Article  PubMed  CAS  Google Scholar 

  12. Bergman R (1994) The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol 30: 236–242

    Article  PubMed  CAS  Google Scholar 

  13. Rohrich RJ, Janis JE, Pownell PH (2002) Xanthelasma palpebrarum: a review and current management principles. Plast Reconstr Surg 110: 1310–1314

    Article  PubMed  Google Scholar 

  14. Orfanos CE, Garbe C (2002) Therapie der Hautkrankheiten, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo

  15. Kuner N, Hartschuh W, Kahn-Durani B (2003) Heinrich Köbner und der „isomorphe Reizeffekt“. Hautarzt 54(3): 274–278

    PubMed  Google Scholar 

  16. Derrick EK, Price ML (1993) Plane xanthomathosis with chronic lymphatic leukämia. Clin Exp Dermatol 18: 259–260

    Article  PubMed  CAS  Google Scholar 

  17. Ito T, Tokura Y, Yoshinari Y et al. (2000) Normalipaemic plane xanthomatosis associated with mycosis fungoides. Br J Dermatol 142: 1235–1236

    Article  PubMed  CAS  Google Scholar 

  18. Gimenez S, Gallardo F, Curco N et al. (2005) Dystrophic xanthomatosis in primary CD30-positive cutaneous T-cell lymphoma. Report of two cases and review of the literature. Dermatology 211: 267–272

    Article  PubMed  Google Scholar 

  19. Rajan N, Carmichael AJ, Bramble MG, Hudson M (2006) Cutaneous xanthomatosis: a novel presention of hypercholesterinämie in primary sclerosing cholangitis. Br J Dermatol 155: 207–229

    Article  Google Scholar 

  20. Macias-Rodriguez RU, Torre-Delgadillo A (2006) Xanthelasmas and xanthomatas striatum palmare in primary biliary cirrhosis. Ann Hepatol 5: 49

    PubMed  Google Scholar 

  21. Timea C, Folhoffer A, Horvath A et al. (2006) Xanthomatosis and extreme hypercholesterolemia after laparoscopic cholecystectomy. Total reversibility following surgical treatment of iatrogenous stenosis of the common bile duct (abstract). Orv Hetil 147: 705–710

    PubMed  Google Scholar 

  22. Fuessl HS (1999) Eruptions „overnight“. Eruptive xanthomas in secondary type IV hyperlipoproteinemia caused by diabetes mellitus. MMW Fortschr Med 141: 47–48

    Google Scholar 

  23. Rubins HB, Robins SJ, Collins D et al. (2002) Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med 162: 2597–2604

    Article  PubMed  CAS  Google Scholar 

  24. Yuan G, Al-Shali KZ, Hegele RA (2007) Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 176: 1113–1120

    PubMed  Google Scholar 

  25. Oh RC, Lanier JB (2007) Management of hypertriglyceridemia. Am Fam Physician 75: 1365–1371

    PubMed  Google Scholar 

  26. Hooper L, Thompson RL, Harrison RA et al. (2006) Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 332: 752–760

    Article  PubMed  CAS  Google Scholar 

  27. Hasengschwandtner F (2005) Die subcutane Injektion von Phosphatidylcholin (Lipostabil N®) zum Zwecke der Lipolyse. Akt Dermatol 31: 549–552

    Article  Google Scholar 

  28. Orth M, Wenig W, Funke H et al. (1999) Effects of a frequent apolipoprotein E isoform ApoE4 (Freiburg) (Leu28-Pro) on lipoproteins and the prevalence of coronary artery disease in Whites. Arterioscler Thromb Vasc Biol 19: 1306–1315

    PubMed  CAS  Google Scholar 

  29. Luc G, Bard JM, Arveiler D et al. (1994) Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 14: 1412–1419

    PubMed  CAS  Google Scholar 

  30. Civeira F, Pocovi M, Cenarro A et al. (1996) Apo E variants in patients with type III hyperlipoproteinemia. Atherosclerosis 127: 273–282

    Article  PubMed  CAS  Google Scholar 

  31. Burnside NJ, Alberta L, Robinson-Bostom L, Bostom A (2005) Type III hyperlipoproteinemia with xanthomas and multiple myeloma. J Am Acad Dermatol 53: S281–284

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Renner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Renner, R., Teuwen, I., Harth, W. et al. Eruptive Xanthome bei Hypertriglyzeridämie. Hautarzt 59, 995–999 (2008). https://doi.org/10.1007/s00105-008-1534-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-008-1534-y

Schlüsselwörter

Keywords

Navigation